EPEN-08. PHARMACOGENOMICS REVEALS ERBB2 AS A THERAPEUTIC TARGET IN PRIMARY EPENDYMOMA CULTURES

Ependymoma represents the third most common brain tumor entity of childhood. Successful targeted treatment approaches especially for RELA fusion-positive supratentorial ependymomas and posterior fossa type A ependymomas, the two subgroups known to be associated with worst prognosis, have so far not...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Pauck, David, Sarikaya-Seiwert, Sevgi, Marquardt, Viktoria, Paisana, Eunice, Picard, Daniel, Bartl, Jasmin, Blümel, Lena, Maue, Mara, Dimitriadis, Christian, Taban, Kübra, Fischer, Ute, Steiger, Hans Jakob, Faria, Cláudia, Reifenberger, Guido, Borkhardt, Arndt, Beez, Thomas, Remke, Marc
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Ependymoma
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477376/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.065
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi